PhD in Biology. Human genetics, complex diseases. Assistant professor at @GeneticaFmed 🇺🇾
@fmed_divulga @SocUruguayaGen @PedecibaB
@spereyra.bsky.social
Curso teórico-práctico:
“Aspectos celulares y moleculares de la Reproducción. Nuevas Perspectivas en Fertilidad.”
19-29 Mayo de 2026 Facultad de Medicina
https://t.co/aTQIpfZrYR
A monumental moment in medical history: the first gene therapy for genetic hearing loss is now FDA approved. As a former Regeneron scientist, I feel very proud. I had the opportunity to hear about this programme while it was still in development. It’s one of the few programmes that, every time you came across it, you felt the medical breakthrough in your bones and privileged just to be there while it was happening.
At this moment, it’s important that we look 30 years back when researchers mapped a locus on chromosome 2 to congenital deafness in a Lebanese family (https://t.co/o8ltjHyLNy). They named it DFNB6 (later DFNB9) with no clue about the responsible gene. Three years later, the causal gene came to light: OTOF, encoding a protein called otoferlin (https://t.co/tBGlFPzaQd). Seven years after that, in 2006, pioneering work by Christine Petit revealed that otoferlin is a calcium sensor in the inner hair cell membrane, acting as a molecular trigger that converts sound into electric signals that the brain can read (https://t.co/oxXtifPrTZ). Twenty years fast forward, we now have a successful treatment. Thirty years from discovery to medicine.
OTOF-related deafness is congenital, caused by complete deficiency of otoferlin. In these children, the cochlea is structurally intact, hair cells are there, the mechanics of sound transmission work. It’s just that final step, where hair cells hand off the signal to the auditory nerve through neurotransmitter release, that doesn’t happen. Sound arrives and dies at the synapse. It’s deafness due to a defect in the synapse caused by the absence of a single protein, which is what made this a beautiful, clean target for gene therapy.
The treatment itself is a feat of molecular engineering. OTOF is too large to fit in a single AAV capsid. The team solved this elegantly by delivering the gene in two halves separately, which then get spliced to produce the full functional protein. A single surgical injection into the cochlea, a molecular miracle unfolds. Results from the CHORD trial were striking: of 20 evaluable patients, including children as young as 10 months, 80% showed meaningful hearing improvement, and by 48 weeks, 42% had achieved normal hearing including the ability to hear whispers. Otarmeni is not only the first gene therapy for deafness, it’s also the first dual-AAV therapy to be approved by the FDA.
There are very few things in medicine that come close to giving back a sense like vision, hearing, or touch that a human never had from birth. It’s almost God’s work. A parent witnessing their child who was born deaf hearing their voice for the first time, it’s a joy that no words can describe. Multiply that by the fact that it came from a single injection, a repaired gene, and 30 years of science. We are truly in the golden era of medicine.
Regeneron press release:
https://t.co/6zvdsT2uzI
Below video is from the NEJM publication of CHORD trial (Valayannopoulos et al. NEJM 2025)
https://t.co/YvIqwQ0SDu
Ahi estaremos dictando un taller sobre cómo analizar variantes genéticas humanas, junto a @MonicaCappetta
Inscripciones abiertas hasta el 4/feb aquí https://t.co/mXz0jq9YnO
@GeneticaFmed
Conocé la agenda de Campus del Sur y las propuestas de formación vinculadas a las diferentes áreas temáticas.
Un espacio de formación con talleres y conferencias con especialistas nacionales e internacionales.
📅 ¡Te esperamos del 10 al 12 de febrero! https://t.co/a4lLhaSYQp
No hay nada mejor que monitorear los resultados de secuenciación en tiempo real!!
Analizando un panel de 90 genes mediante Adaptative sampling en MinION de @nanopore en muestras de Leucemia Mieloide Aguda.
Desde @GeneticaFmed buscamos implementar desarrollos costo-efectivos 💪🏻
¡Este viernes, vuelve #MedicinaInvestiga! 👩🔬
🙌 Vení a conocer esta feria de ciencias con stands, charlas y actividades que buscan acercar la investigación a toda la comunidad.
📅 31 de octubre
🕙 10 a 17h
📍 @fmedoficial
🎟️ Entrada libre y gratuita
Excited to share our new paper! Proud to contribute to the wonderful and expanding single-cell transcriptomics community in LATAM — and to this fantastic team who made it possible! 🙌
@GeneticaFmed
Featuring a Commentary with a Latin American focus on transcriptomics. The regions’s genetic diversity, environment, and endemic infectious diseases offer opportunities to deploy these technologies for societal and scientific impact. https://t.co/1NJTivC0vJ
Un placer escuchar esta mesa, compartiendo miradas sobre este tema tan fascinante:
La Mesa de Científicos: ¿Qué es la divulgación científica y por qué es tan importante? https://t.co/KNsqtA03KG
Grandes todos los panelistas 💪@BTassino
Look our last paper: the first study in #LatinAmerica that describes gene promoter methylation in Severe Preterm Birth using @nanopore technology!! 🧬🧬
https://t.co/eEiGJzf7m3
💡 ¿Puede la epigenética ayudar a entender el parto prematuro?
La #InvestigadoraPEDECIBA Silvana Pereyra estudia la metilación del ADN en recién nacidos para identificar factores genéticos vinculados a este fenómeno.
6° capítulo de la serie #DespegueCientífico#CienciaUy
Apply for a free place on our #HelminthBio25 course, in Uruguay! 🇺🇾
⏰Deadline: 18 February 2025
Join experts from #LatAm for an introduction into accessing, analysing and presenting large-scale #genomics data, relevant to #helminth studies 🐛
📎 Info: https://t.co/a9QTorWpRv
En el Laboratorio de Epidemiología Genética de @GeneticaFmed, la Dra. Silvana Pereyra viene estudiando marcadores genéticos, epigenéticos y de ARN en parto prematuro severo! Aportando su granito de arena para intentar disminuir esta patología en nuestro país!
👩🔬 ¡Se viene Medicina Investiga, la feria de Ciencias de @fmedoficial!
🙌 Vení a conocer los trabajos de más de 80 investigadores e investigadoras en los stands, actividades, charlas y audiovisuales.
🗓️15/11
⏰10 a 17h
📍@fmedoficial y cercanías
➕info: https://t.co/JfQj0eyJnC
Tenemos buenas noticias para todos nuestros socios y amigos de américa latina, ¡el próximo #ALAG2026 será en Montevideo! Para que vayan calentando motores les dejamos el video de nuestra postulación a @alagenetica y esperamos verlos a todos en 🇺🇾
Gran honor el de presentar un trabajo colaborativo en #SingleCell de los participantes del #SingleCellRio23 en el Simposio de #SingleCellRio24. Otra demostración de la posibilidad de realizar trabajos colaborativos de alto calibre entre los países latinoamericanos.
And it's a wrap for #SingleCellRio2024! @BoroniMariana gives a great closing speech for this conference, with 100 participants from across Latin America and more! 🇧🇷🇲🇽🇨🇷🇺🇾🇻🇪🇦🇷🇵🇪🇨🇱🇨🇴 Thanks to all organisers for a great symposium 😀